• Activity INFORMATION

  Overview

  We live in an "Opioid Epidemic" where someone dies approximately every 15 minutes from prescription drug overdose. So just how do we end this "Opioid Epidemic" or at least, how do we as healthcare professionals contribute to the progress of society in the right direction? In this monograph, we will discuss overall pain management etiology, specific opioid medication pharmacological concepts, opioid overdose reversal treatments, and not only how to identify drug seeking and diversion behaviors, but possible actions to take when the behaviors are suspected. Unlike opioids, this monograph is intended to open one's eyes, elevate blood pressure and/or heart rate, and increase cognition (in relation to appropriate pain management).

  Rating

     4.50  out of 5

  Handouts

  • Homestudy PDF :   HomestudyPDF_17125H04.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Explain how to be compliant with federal and state controlled substances laws.

  Describe when and how to initiation, continue, or discontinue opioid medications for the management of patients experiencing pain based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines. Concepts will include a review of patient evaluation and risk assessment tools; pain treatment objectives; patient and provider(s) agreements; urine screenings; pill counts; patient education on the safe use, storage and disposal of controlled substances; drug interactions; toxicities; & discontinuation and tapering of opioids.

  Describe the best practices for identifying 'red flag' patient drug seeking & diversion behaviors, and ultimately working with patients, prescribers, law enforcement, and others as appropriate, concerning patients suspected of drug seeking behavior and diversion.

  Describe the etiology and epidemiology of chronic pain.

  Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.

  Explain the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment.

  Pharmacy Technician

  Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.

  Describe the etiology and epidemiology of chronic pain.

  Explain how to ensure that the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment are in place within a pharmacy practice.

  Describe the best practices for identifying ??red flag????patient drug seeking & diversion behaviors, and ultimately working with patients, prescribers, law enforcement, and others as appropriate, concerning patients suspected of drug seeking behavior and diversion.

  Explain how to be compliant with federal and state controlled substances laws.

  Identify the best practices for the use of opioid medications based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines. Concepts will include a review of patient evaluation and risk assessment tools; pain treatment objectives; patient and provider(s) agreements; urine screenings; pill counts; patient education on the safe use, storage and disposal of controlled substances; drug interactions; toxicities; & discontinuation and tapering of opioids.

  Nurse

  Describe the best practices for identifying 'red flag' patient drug seeking & diversion behaviors, and ultimately working with patients, prescribers, law enforcement, and others as appropriate, concerning patients suspected of drug seeking behavior and diversion.

  Describe when and how to initiation, continue, or discontinue opioid medications for the management of patients experiencing pain based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines. Concepts will include a review of patient evaluation and risk assessment tools; pain treatment objectives; patient and provider(s) agreements; urine screenings; pill counts; patient education on the safe use, storage and disposal of controlled substances; drug interactions; toxicities; & discontinuation and tapering of opioids.

  Describe the etiology and epidemiology of chronic pain.

  Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.

  Explain the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment.

  Explain how to be compliant with federal and state controlled substances laws.

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-608272

  Universal Activity Number

  Pharmacist 0798-0000-17-125-H04-P
  Pharmacy Technician 0798-0000-17-125-H04-T
  Nurse 0798-0000-17-125-H04-P
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Mark  Garofoli, PharmD, MBA, BCGP, CPE Assistant Professor, West Virginia University School of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).